These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9264999)

  • 1. [Is there a reliable immunotherapy in infection?].
    Grimminger F; Mayer K; Seeger W
    Internist (Berl); 1997 Jun; 38(6):541-52. PubMed ID: 9264999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems and perspective approaches to correction of mediator response in sepsis].
    Mironov PI; Rudnov VA
    Anesteziol Reanimatol; 1999; (3):54-9. PubMed ID: 10458039
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential strategies for inflammatory mediator manipulation: retrospect and prospect.
    Fisher CJ; Zheng Y
    World J Surg; 1996 May; 20(4):447-53. PubMed ID: 8662133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [OPINION OF ANESTHESIOLOGIST ON PATHOGENESIS OF SHOCK, TAKING INTO ACCOUNT THE INFUSION THERAPY POINT OF VIEW].
    Ivakhnenko EV
    Klin Khir; 2015 Sep; (9):69-71. PubMed ID: 26817094
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DR monitoring in the intensive care unit--more than a tool for the scientist in the laboratory?
    Flohé S; Scholz M
    Crit Care Med; 2009 Oct; 37(10):2849-50. PubMed ID: 19865013
    [No Abstract]   [Full Text] [Related]  

  • 6. [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
    Holzmann B; Weighardt H; Heidecke CD
    Chirurg; 2003 Jan; 74(1):61-4. PubMed ID: 12552407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of neonatal sepsis and septic shock].
    Wojsyk-Banaszak I; Szczapa J
    Przegl Epidemiol; 2006; 60(1):119-26. PubMed ID: 16758750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune response to trauma.
    Harris BH; Gelfand JA
    Semin Pediatr Surg; 1995 May; 4(2):77-82. PubMed ID: 7633853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal responses to injury prevent systemic inflammation and can be immunosuppressive.
    Munford RS; Pugin J
    Am J Respir Crit Care Med; 2001 Feb; 163(2):316-21. PubMed ID: 11179099
    [No Abstract]   [Full Text] [Related]  

  • 10. Advances in immunotherapy of sepsis.
    Klein DM; Witek-Janusek L
    Dimens Crit Care Nurs; 1992; 11(2):75-89. PubMed ID: 1576902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis criteria, and selection of patients for immunotherapy.
    Thijs LG
    Prog Clin Biol Res; 1994; 388():407-15. PubMed ID: 7831372
    [No Abstract]   [Full Text] [Related]  

  • 12. Thirty years of anti-mediator treatment in sepsis and septic shock--what have we learned?
    Neugebauer E; Rixen D; Raum M; Schäfer U
    Langenbecks Arch Surg; 1998 Mar; 383(1):26-34. PubMed ID: 9627168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis.
    Faist E; Kim C
    New Horiz; 1998 May; 6(2 Suppl):S97-102. PubMed ID: 9654318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute septic cardiomyopathy].
    Müller-Werdan U
    Internist (Berl); 1998 May; 39(5):467-78. PubMed ID: 9647981
    [No Abstract]   [Full Text] [Related]  

  • 15. Septic shock: current concepts.
    Brampton WJ
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):127-9. PubMed ID: 9166369
    [No Abstract]   [Full Text] [Related]  

  • 16. The inflammatory/immune response in critical illness: role of the systemic inflammatory response syndrome.
    Secor VH
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):251-64. PubMed ID: 7946186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-quality enteral nutrition essential for reducing morbidity and mortality in acute care patients.
    Curtis L
    Crit Care Med; 2007 Mar; 35(3):988; author reply 988. PubMed ID: 17421112
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis.
    Nishida O; Nakamura T; Kuriyama N; Hara Y; Yumoto M; Shimomura Y; Moriyama K
    Contrib Nephrol; 2011; 173():172-181. PubMed ID: 21865790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disordered hemostasis related to sepsis and SIRS].
    Riess H
    Internist (Berl); 1998 May; 39(5):479-84. PubMed ID: 9647982
    [No Abstract]   [Full Text] [Related]  

  • 20. [Septic shock and systemic inflammatory response syndrome--treatment].
    Müller-Werdan U
    Dtsch Med Wochenschr; 2003 Nov; 128(45):2372-6. PubMed ID: 14606035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.